May 4 (Reuters) - Actinogen Medical Ltd (ACW) :
- ACTINOGEN MEDICAL LTD - CONDUCTED A REASSESSMENT OF ITS PRIORITIES AND PLANNED EXPENDITURES, RESULTING IN STRATEGIC ADJUSTMENTS
- ACTINOGEN MEDICAL - STRATEGIC ADJUSTMENTS TO PRIORITIZE ALZHEIMER'S DISEASE & MAJOR DEPRESSIVE DISORDER PROGRAMS FOR XANAMEM
- ACTINOGEN MEDICAL - SUSPEND CLINICAL TRIAL OPERATIONS FOR ITS XANAFX FRAGILE X SYNDROME TRIAL & REALLOCATE THOSE RESOURCES TO AD AND MDD
- Forums
- ASX - By Stock
- ACW
- News: ACW Actinogen Medical Says Reassessed Priorities & Expenditures Resulting In Strategic...
ACW
actinogen medical limited
Add to My Watchlist
0.00%
!
2.7¢

News: ACW Actinogen Medical Says Reassessed Priorities & Expenditures Resulting In Strategic...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.73M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 533350 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 797223 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2151007 | 0.029 |
4 | 2250000 | 0.028 |
10 | 1313003 | 0.027 |
9 | 3218090 | 0.026 |
14 | 2446589 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 40079 | 1 |
0.031 | 1604999 | 5 |
0.032 | 3328459 | 9 |
0.033 | 631127 | 8 |
0.034 | 215322 | 4 |
Last trade - 09.42am 15/09/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online